Naia, Luana
Pinho, Catarina M.
Dentoni, Giacomo
Liu, Jianping
Leal, Nuno Santos
Ferreira, Duarte M. S.
Schreiner, Bernadette
Filadi, Riccardo
Fão, Lígia
Connolly, Niamh M. C.
Forsell, Pontus
Nordvall, Gunnar
Shimozawa, Makoto
Greotti, Elisa
Basso, Emy
Theurey, Pierre
Gioran, Anna
Joselin, Alvin
Arsenian-Henriksson, Marie
Nilsson, Per
Rego, A. Cristina
Ruas, Jorge L.
Park, David
Bano, Daniele
Pizzo, Paola
Prehn, Jochen H. M.
Ankarcrona, Maria https://orcid.org/0000-0002-7022-3694
Funding for this research was provided by:
Joint Programme in Neurodegenerative Disorders (JPND_CD_FP-688-025)
Karolinska Institute
Article History
Received: 17 April 2020
Accepted: 11 February 2021
First Online: 24 March 2021
Ethics approval and consent to participate
: Ethics approval for these studies were given by the “Regionala Etikprövningsnämnden”, Stockholm and “Linköpings djurförsöksetiska nämnd” (Regional Ethics Review Board, authorization no. S53-14, ID407 and 12779/2019). For Ca<sup>2+</sup> experiments, all procedures were approved by the Italian Ministry of Health (authorization no. D2784.N.HEH, 03/07/18). Experiments in YAC128 mouse model were approved by the Faculty of Medicine, University of Coimbra (authorization no. ORBEA_189_2018/11042018).
: Not applicable.
: The authors declare that they have no competing interests.